April 16, 2026: Ozempic & GLP-1 MDL Passes 3,500 Cases The number of lawsuits in a federal MDL alleging severe gastrointestinal side effects from taking GLP-1s like Ozempic has climbed to 3,546
No dedicated clinical trials have specifically evaluated semaglutide's impact on male or female fertility parameters in humans
There have been reports of patients mistakenly dialing the pen to the maximum dose, which has resulted in calls to poison centers for help

Tirzepatide tends to be the better choice if: You have a higher starting BMI (say, above 35) and want maximum weight loss You also have type 2 diabetes and need stronger glycemic control You've tried semaglutide and plateaued before reaching your goal Cost is similar for you (LillyDirect direct-pay vials currently undercut Wegovy on entry tiers) Semaglutide tends to be the better choice if: You have established cardiovascular disease and want a drug with proven CV outcome benefit (SELECT) [9] You tolerated 1 mg Ozempic well in the past and your insurance covers Wegovy You prefer the longer real-world track record (Wegovy approved 2021 versus Zepbound 2023) You need an oral option (Rybelsus, though it's FDA-approved for diabetes, not weight loss) Either is reasonable if: You're starting from BMI 30 to 35 with no major comorbidities Your insurance pushes you toward one over the other You're in the early titration period and haven't yet seen what your response looks like A real-world example

Balanced Nutrition Regular exercise Drinking plenty of water Making sure enough protein and fiber is mixed into your diet Reduce processed foods and sugary beverages Avoid alcohol Choosing food that is easily digestable Eating small portions more often, versus large meals
At Russald Medical Center in Tijuana, Mexico, semaglutide is prescribed and monitored by a licensed physician after a medical evaluation